Detalhe da pesquisa
1.
Role of myeloid-derived suppressor cells in tumor recurrence.
Cancer Metastasis Rev
; 42(1): 113-142, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640224
2.
Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
Biol Blood Marrow Transplant
; 26(1): e7-e15, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31526843
3.
Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients.
Future Oncol
; 15(17): 1989-1995, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170814
4.
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 973-982, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307717
5.
Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.
Biol Blood Marrow Transplant
; 22(5): 869-78, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26827660
6.
Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Biol Blood Marrow Transplant
; 21(1): 159-64, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445637
7.
High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.
Biol Blood Marrow Transplant
; 20(7): 979-85, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24709007
8.
Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant.
J Clin Apher
; 29(6): 293-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24700728
9.
Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia.
Leuk Res
; 139: 107467, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460432
10.
Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
Hematology
; 29(1): 2326384, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597828
11.
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.
Biol Blood Marrow Transplant
; 19(1): 56-61, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22892551
12.
CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma.
Biol Blood Marrow Transplant
; 19(6): 925-33, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23529012
13.
A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.
Am J Hematol
; 93(4): E96-E98, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318650
14.
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.
Support Care Cancer
; 21(9): 2437-42, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591714
15.
Highlights into historical and current immune interventions for cancer.
Int Immunopharmacol
; 117: 109882, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848790
16.
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 18(11): 1734-44, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22710143
17.
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial.
Biol Blood Marrow Transplant
; 18(9): 1455-61, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22453252
18.
Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial.
Support Care Cancer
; 20(10): 2363-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22193771
19.
Enrichment of innate immune cells from PBMC followed by triple cytokine activation for adoptive immunotherapy.
Int Immunopharmacol
; 113(Pt A): 109387, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36461582
20.
Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia.
J Geriatr Oncol
; 13(6): 871-874, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35450817